[1] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663.
[2] Briggs R, King TJ. Transplantation of living nuclei from blastula cells into enucleated frogs'eggs[J]. Proc Natl Acad Sci,1952, 38(5): 455.
[3] Miller RA, Ruddle FH. Pluripotent teratocarcinoma-thymus somatic cell hybrids[J]. Cell,1976,9(1): 45.
[4] Xie H, Ye M, Feng R, et al. Stepwise reprogramming of B cells into macrophages[J]. Cell,2004, 117(5): 663.
[5] Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts[J]. Cell,1987, 51(6): 987.
[6] Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors[J]. Cell,2010, 142(3): 375.
[7] Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes[J]. Nat Biotechnol,2008, 26(11): 1276.
[8] Eminli S, Utikal J, Arnold K, et al. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression[J]. Stem Cells,2008, 26(10): 2467.
[9] Utikal J, Maherali N, Kulalert W, et al. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells[J]. J Cell Sci,2009, 122(Pt 19): 3502.
[10] Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic β cells into induced pluripotent stem cells[J]. Curr Biol,2008, 18(12): 890.
[11] Sun N, Panetta NJ, Gupta DM, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells[J]. Proc Natl Acad Sci USA, 2009,106(37):15720.
[12] Hanna J, Markoulaki S, Schorderet P, et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency[J]. Cell,2008, 133(2): 250.
[13] Zhao XY, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation[J]. Nature,2009, 461(7260): 86.
[14] Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells[J]. Nature,2007, 448(7151): 313.
[15] Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration[J]. Science,2008, 322(5903): 945.
[16] Varas F, Stadtfeld M, de Andres-Aguayo L, et al. Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions[J]. Stem Cells,2009, 27(2): 300.
[17] Fusaki N, Ban H, Nishiyama A, et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome[J]. Proc Jpn Acad,2009, 85(8): 348.
[18] Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences[J]. Science,2009, 324(5928): 797.
[19] Jia F, Wilson KD, Sun N, et al. A nonviral minicircle vector for deriving human iPS cells[J]. Nat Methods,2010, 7(3): 197.
[20] Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells[J]. Nature,2009, 458(7239): 766.
[21] Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins[J]. Cell Stem Cell,2009, 4(5): 381.
[22] Cho HJ, Lee CS, Kwon YW, et al. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation[J]. Blood,2010, 116(3): 386.
[23] Desponts C, Ding S. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells[J]. Methods Mol Biol,2010, 636: 207.
[24] Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells[J]. Cell,2008, 134(5): 877.
[25] Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient[J]. Nature,2009, 457(7227): 277.
[26] Lee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs[J]. Nature,2009,461(7262): 402.
[27] Carvajal-Vergara X, Sevilla A, D'Souza SL, et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome[J]. Nature,2010,465(7299): 808.
[28] Hanna J, Wernig M, Markoulaki S, et al.Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin[J]. Science,2007, 318(5858): 1920.
[29] M. Wernig, J. Pruszak, E. Hedlund, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease[J].Proc Natl Acad Sci,2008,105(15) : 5856.
[30] D. Xu, LM. Fink, DM. Adcock, et al. Phenotypic correction ofmurine hemophilia A using an iPS cell-based therapy[J]. Proc Natl Acad Sci,2009,106(3) :808.
[31] T.J. Nelson, S. Yamada, C. Perez-Terzic, et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells[J].Circ,2009,120(5) :408.
[32] Raya A, Rodriguez-Piza I, Guenechea G et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells[J]. Nature,2009, 460(7251):53.
[33] Couzin J. Celebration and concern over U.S. trial of embryonic stem cells[J]. Science,2009,323(5914):568.